Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Neurology Diabetes / Metabolic Women's Health Rheumatology Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Clinical Trial ● Currently Recruiting NCT07129616

Remote Monitoring of Asthma in Children and Young People

Remote Monitoring of Asthma in Children and Young People — Recruiting • Respiratory / COPD / Asthma • NCT07129616.

📅 27 Oct 2026 ⏱ 1 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
NCT ID
NCT07129616
Sponsor
University of Edinburgh
Start
2025-11-20
ClinicaliQ Trial Snapshot
  • Remote Monitoring of Asthma in Children and Young People — Recruiting • Respiratory / COPD / Asthma • NCT07129616.
  • Sponsor: University of Edinburgh.

Verify eligibility, endpoints and current status on the original source registry before acting on this summary.

Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

The objective of this study is to determine whether healthcare data and remotely collected patient data can accurately predict asthma attacks in children and young people aged 5-17 years. The main outcome is: when using this new system, is there a reduction in asthma attacks compared with a historic average. The whole population of children and young people with asthma will have routine healthcare data monitored, with a subset of people with high risk asthma asked to participate in a more detail study involving remotely monitored data.

Eligibility Snapshot
  • : * Children and Young People with a diagnosis of asthma (coded as asthma or suspected asthma) or a prescription of inhaled corticosteroid in the prior 2 years.

Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Clinical Brief
I’m 12 and I want to try protein powder – should I?
Respiratory / COPD / Asthma · BBC Health · 15 Oct 2026
Protein powder safety in children requires expert assessment of individual nutritional needs rather than routine use, as most UK children obtain adequate…
View brief →
Clinical Brief
Children as young as six going to A&E in mental health crisis
Respiratory / COPD / Asthma · BBC Health · 02 Sep 2026
Children as young as six are presenting to A&E with acute mental health crises, including self-harm and eating disorders, indicating a significant…
View brief →
Clinical Brief
‘Wildly unfair that my husband and I pay £4k a year for ADHD treatment’
Respiratory / COPD / Asthma · BBC Health · 23 Oct 2026
Northern Ireland lacks a formally commissioned adult ADHD service, unlike the rest of the UK, forcing patients to pursue private treatment at…
View brief →
Guideline
XVIVO Perfusion System (ex-situ machine perfusion) for assessing and reconditioning marginal lungs for transplantation: early-use assessment
Respiratory / COPD / Asthma · 21 Oct 2026
XVIVO Perfusion System enables ex-situ assessment of marginal donor lungs before transplantation, allowing objective evaluation of organ viability and function to improve…
View guideline →
Clinical Brief
AI sleep data could provide one-week early warning of flu and COVID-19
Respiratory / COPD / Asthma · UKHSA · 03 Sep 2026
Sleep-tracking apps analysing cough patterns can detect flu and COVID-19 approximately one week before symptom onset, potentially enabling early intervention and isolation…
View brief →
Guideline
Brensocatib for treating non-cystic fibrosis bronchiectasis in people 12 years and over (terminated evaluation)
Respiratory / COPD / Asthma · 25 Aug 2026
Evaluation terminated: Brensocatib for non-CF bronchiectasis is no longer under NICE appraisal—do not initiate new treatment pathways for this indication pending alternative…
View guideline →